Dr. Eric Achtyes, MD

NPI: 1780665976
Total Payments
$106,778
2024 Payments
$14,722
Companies
13
Transactions
182
Medicare Patients
413
Medicare Billing
$77,922

Payment Breakdown by Category

Consulting$42,993 (40.3%)
Other$36,492 (34.2%)
Travel$21,357 (20.0%)
Food & Beverage$5,866 (5.5%)
Education$69.57 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $42,993 26 40.3%
Honoraria $29,293 13 27.4%
Travel and Lodging $21,357 56 20.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,199 13 6.7%
Food and Beverage $5,866 72 5.5%
Education $69.57 2 0.1%

Top Paying Companies

Company Total Records Latest Year
H. Lundbeck A S $35,830 29 $0 (2023)
Alkermes, Inc. $21,947 38 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $12,977 28 $0 (2024)
Indivior Inc. $11,979 17 $0 (2023)
Neurocrine Biosciences, Inc. $9,768 30 $0 (2024)
Janssen Pharmaceuticals, Inc $5,106 5 $0 (2018)
Teva Pharmaceuticals USA, Inc. $3,480 2 $0 (2022)
Sunovion Pharmaceuticals Inc. $2,133 13 $0 (2022)
F. Hoffmann-La Roche AG $1,758 5 $0 (2019)
Janssen Research & Development, LLC $1,264 8 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $14,722 21 Boehringer Ingelheim Pharmaceuticals, Inc. ($11,593)
2023 $11,672 28 H. Lundbeck A S ($5,358)
2022 $6,373 5 H. Lundbeck A S ($4,510)
2021 $14,847 9 H. Lundbeck A S ($13,107)
2020 $15,502 27 H. Lundbeck A S ($8,140)
2019 $9,425 18 H. Lundbeck A S ($4,715)
2018 $31,668 52 Alkermes, Inc. ($10,826)
2017 $2,569 22 Boehringer Ingelheim Pharmaceuticals, Inc. ($1,292)

All Payment Transactions

182 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
11/19/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $2,843.75 General
10/29/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Education In-kind items and services $27.27 General
Category: Psychiatry/Psychology
06/10/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $5,785.00 General
06/10/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $140.00 General
06/10/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $35.00 General
06/03/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,478.75 General
05/28/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $113.52 General
Category: Neuropsychiatry
05/01/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $124.65 General
05/01/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $45.47 General
04/26/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $122.43 General
04/25/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $41.63 General
04/25/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $34.48 General
04/25/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $29.17 General
04/25/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $28.66 General
04/24/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $279.00 General
04/16/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $605.17 General
02/13/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $1,320.00 General
Category: CNS
01/16/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Travel and Lodging In-kind items and services $1,060.30 General
Category: CNS
01/16/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Travel and Lodging In-kind items and services $271.00 General
Category: CNS
01/16/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $215.48 General
Category: CNS
01/16/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $121.09 General
Category: CNS
07/03/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $840.00 General
Category: CNS
05/11/2023 H. Lundbeck A S ABILIFY MAINTENA (Drug) Honoraria Cash or cash equivalent $4,038.00 General
Category: PSYCHIATRY
05/11/2023 H. Lundbeck A S ABILIFY MAINTENA (Drug) Travel and Lodging Cash or cash equivalent $535.90 General
Category: PSYCHIATRY
05/11/2023 H. Lundbeck A S ABILIFY MAINTENA (Drug) Travel and Lodging Cash or cash equivalent $335.44 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 27 30 $3,569 $481.55
2022 6 145 445 $83,592 $18,571
2021 6 184 681 $128,759 $31,188
2020 1 57 334 $116,900 $27,682
Total Patients
413
Total Services
1,490
Medicare Billing
$77,922
Procedure Codes
15

All Medicare Procedures & Services

15 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 12 13 $2,356 $414.60 17.6%
96372 Injection of drug or substance under skin or into muscle Office 2023 15 17 $1,212 $66.95 5.5%
90870 Therapy using electrical currents Facility 2022 35 132 $47,652 $10,755 22.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 29 54 $11,122 $2,851 25.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 17 28 $6,752 $2,472 36.6%
96372 Injection of drug or substance under skin or into muscle Office 2022 38 198 $14,121 $1,324 9.4%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 12 14 $1,190 $608.69 51.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 14 19 $2,755 $559.64 20.3%
90870 Shock treatment and monitoring Facility 2021 56 265 $94,312 $22,128 23.5%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 30 47 $3,995 $2,829 70.8%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2021 40 290 $20,469 $2,790 13.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 22 30 $6,179 $1,850 29.9%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 25 34 $1,700 $1,071 63.0%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 11 15 $2,104 $519.48 24.7%
90870 Shock treatment and monitoring Facility 2020 57 334 $116,900 $27,682 23.7%

About Dr. Eric Achtyes, MD

Dr. Eric Achtyes, MD is a Psychiatry healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780665976.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Achtyes, MD has received a total of $106,778 in payments from pharmaceutical and medical device companies, with $14,722 received in 2024. These payments were reported across 182 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($42,993).

As a Medicare-enrolled provider, Achtyes has provided services to 413 Medicare beneficiaries, totaling 1,490 services with total Medicare billing of $77,922. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Grand Rapids, MI
  • Active Since 11/07/2005
  • Last Updated 01/25/2023
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1780665976

Products in Payments

  • ABILIFY MAINTENA (Drug) $32,820
  • PERSERIS (Drug) $9,906
  • Aristada 441 mg (Drug) $8,170
  • ARISTADA (Drug) $7,613
  • INGREZZA (Drug) $4,718
  • BRINTELLIX (Drug) $3,010
  • AUSTEDO (Drug) $1,845
  • INVEGA TRINZA (Drug) $1,277
  • SYMTUZA (Drug) $111.71
  • COBENFY (Drug) $27.27

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Grand Rapids